Please assess the completion status of the following clinical trial:

Trial Title: Transcranial Magnetic Stimulation (TMS) for Primary Progressive Apraxia of Speech (PPAOS)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Adults ages 18 and above who are able to consent~* Diagnosis of primary progressive apraxia of speech based on neurological evaluation~Exclusion Criteria:~* Any uncontrolled medical condition expected to limit life expectancy or interfere with participation in the trial (i.e. unstable cancer, severe depression or anxiety by DSM-IV criteria)~* Abnormal stress test, as determined by the treating physician (unless cardiology clearance provided)~* Active substance abuse or alcohol dependence~* Uncorrected vision or hearing deficits that would preclude administration of the cognitive measures~* Unwilling or unable to provide written informed consent~* History of fainting spells of unknown or undetermined etiology that might constitute seizures~* History of seizures, diagnosis of epilepsy, history of abnormal (epileptiform) EEG or family history of treatment resistant epilepsy~* No medication is an absolute exclusion from TMS. Medications will be reviewed by the responsible MD and a decision about inclusion will be made based on the following:~  * The subject's past medical history, drug dose, history of recent medication changes or duration of treatment, and combination with other CNS active drugs.~ * The published TMS guidelines review medications to be considered with TMS~* Any metal in the brain, skull or elsewhere unless approved by the responsible MD~* Any medical devices (i.e. Cardiac pacemaker, deep brain stimulator, medication infusion pump, cochlear implant, vagal nerve stimulator) unless otherwise approved by the responsible MD~* Substance abuse or dependence within the past six months~* Absence of corticospinal functional integrity

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Transcranial Magnetic Stimulation (TMS) (Type: EXPERIMENTAL): Non-invasive brain stimulation, high frequency repetitive TMS delivered in 10 sessions over a 2-week period.

Based on this trial design, predict the completion outcome and termination type (if applicable).